References
- Studre P, Ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull W H O 1992; 70: 149–59
- Koli A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tuberculosis 1991; 72: 1–12
- Wang XF, Zhang XZ, Du GZ, Wang BY, Zhang Q, Huang J, et al. Immune response of domestically made tuberculin. Chin J Biol 1995; 1: 40–2
- Grange JM. Infection and disease due to environmental mycobacteria. Trans R Soc Trop Med Hyg 1987; 81: 179–82
- Jacobes GG, Johnson JL, Boom WH, Wallis RS, Whalen CC, Ginsberg AM. Tuberculosis vaccines: how close to human testing?. Tuberc Lung Dis 1997; 78: 159–69
- Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393: 537–44
- Jungblut PR, Schaible UE, Mollenkopf HJ, Zimny-Arndt U, Raupach B, Mattow J, et al. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol 1999; 33: 1103–17
- Wilkinson RJ, Haslov K, Rappuoli R, Giovannoni F, Narayanan PR, Desei CR, et al. Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol 1997; 33: 553–7
- Elhay MJ, Oettinger T, Andersen P. Delayed-hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in guinea pigs. Infect Immun 1998; 66: 3454–6
- National Infection Survey Centre of China. Reports on national epidemiology of tuberculosis in 2000. J Chin Antituberc Assoc 2002;24:65–108.
- Braibant M, Lefevre P, de Wit L, Peirs O, Ooms J, Huygen K, et al. A Mycobacterium tuberculosis gene cluster encoding proteins of a phosphate transporter homologous to the Escherichia coli Pst system. Gene 1996; 176: 171–6
- Chang ZY, Choudhary R, Lathigra R, Quicho FA. The immunodominant 38 kDa lipoprotein antigen of Mycobacterium tuberculosis is a phosphate-binding protein. J Biol Chem 1994; 269: 956–8
- Andersen AB, Ljungqvist L, Olsen M. Evidence that protein b of Mycobacterium tuberculosis is involved in phosphate metabolism. J Gen Microbiol 1990; 136: 477–80
- Haslov K, Andersen AB, Ljungqvist L, Weis Bentzon M. Comparison of the immunological activity of 5 defined antigens from Mycobacterium tuberculosis in 7 inbred guinea pig strains: the 38 kDa antigen is immunodominant. Scand J Immunol 1990; 31: 503–14
- He XY, Zhuang YH, Zhang XG, Xiong ZH, Dong EJ, Shi YC. Immunological characteristics of the recombinant 38 kDa antigen from Mycobacterium tuberculosis. Chin J Tuberc Respir Dis 2000; 23: 485–8
- He XY, Zhuang YH, Zhang XG, Xiong ZH, Chang ZY. 38 kDa protein of Mycobacterium tuberculosis is overexpressed in Escherichia coli. Chin J Tuberc Respir Dis 1999; 22: 138–41
- He XY, Zhuang YH, Zhang XG, Dong EJ, Xiong ZH, Chang ZY. Delayed-type hypersensitivity responses to recombinant mycobacterial antigen 38 kDa in guinea pigs sensitized with Mycobacterium tuberculosis. Chin J Tuberc Respir Dis 2000; 23: 161–3
- Vordermeier HM, Harris DP, Friscia G, Roman E, Surcel HM, Moreno C, et al. T-cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38 kDa antigen in patients with active disease. Eur J Immunol 1992; 22: 2631–7
- Wilck JT, Jensen BN, Ravn P, Andersen AB, Haslov K. Clinical evaluation of MPT-64 and MPT-59, 2 proteins secreted from Mycobacterium tuberculosis, for skin test reagents. Tuberc Lung Dis 1996; 77: 250–6
- Aggerbeck H, McNair J, Bassett H, Cassidy JP, Cstel E, Aggerbeck H, et al. Specific delayed-type hypersensitivity responses to ESAT-6 identify tuberculosis-infected cattle. J Clin Microbiol 2003; 41: 1856–60
- Nakamura RM, Einck L, Velmonte MA, Kawajiri K, Ang CF, Delasllagas CE, et al. Detection of active tuberculosis by a MPB-64 transdermal patch: a field study. Scand J Infect Dis 2001; 33: 405–7
- Young D, Kent L, Rees A, Lamb J, Ivanyi J. Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis. Infect Immun 1986; 54: 177–83
- Stanford JL, Shield MJ, Rook GA. How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle 1981; 62: 55–62